DAX6.050-3,4%  Dow12.119-2,2%  Euro1,24320,6% 
ESt502.069-2,4%  Nas2.748-2,8%  Öl98,82-2,8% 
TDax730,9-2,7%  Nikkei8.440-1,2%  Gold1.6264,2% 
Home > Aktien > Cerus Aktie > Nachrichten zu Cerus

Cerus Aktie [WKN: 905249 / ISIN: US1570851014]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime PushmyNews neu IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Cerus Corp.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

Top-Nachrichten

DAX schließt im Plus -- Dow Jones "knackt" 13.000-Punkte-Marke -- Postbank-Übernahme durch Deutsche Bank fast vollendet -- S&P stuft Griechenland ab -- Bayer, Nordex, Q-Cells im Fokus
Arbeitsgericht stoppt Lotsenstreik am Frankfurter Flughafen. CSU will Übergangsfristen für Kürzung der Solarförderung. Apple lädt zu iPad-Vorstellung ein. Bouygues weist Zahlen auf Vorjahresniveau aus. » mehr

Weitere Meldungen

02.03.10Cerus to Present at Cowen and Company Annual Health Care Conference
23.02.10Cerus Announces Fourth Quarter and Year-End 2009 Results
17.02.10Data Presented at International Haemovigilance Seminar Confirm Safety of Cerus' INTERCEPT Blood System for Platelets and Plasma
09.02.10Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development
09.02.10Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells

ANZEIGE

04.02.10Cerus to Release Fourth Quarter and Year-End 2009 Results on February 23, 2010
02.02.10Cerus to Present at 12th Annual BIO CEO & Investor Conference
14.01.10Cerus Corporation Reports Positive Outcome in European Study of 7-Day INTERCEPT Platelets
17.11.09Cerus Corporation Receives FDA Blood Products Advisory Committee Guidance for Proposed INTERCEPT Blood System Phase III Trial Design
16.11.09Cerus Corporation Stock Trading Halted; FDA Blood Products Advisory Committee to Review and Discuss Proposed Phase III Clinical Trial Design for the INTERCEPT Blood System
29.10.09Cerus Corporation Announces Third Quarter Financial Results
12.10.09Cerus to Release Third Quarter Results on October 29, 2009
29.09.09Cerus to Present Proposal for INTERCEPT Platelet US Phase III Clinical Trial at November BPAC Meeting
20.08.09Cerus Corporation Announces Pricing of Common Stock and Warrant Offering
19.08.09Cerus’ INTERCEPT Blood System for Platelets Receives Swiss Approval
30.07.09Cerus Corporation Announces Second Quarter Financial Results
16.07.09Belgium Mandates Universal Pathogen Inactivation for Platelets
15.07.09Cerus to Release Second Quarter Results on July 30, 2009
02.06.09Cerus and Grifols to Collaborate on INTERCEPT Red Cell Kit Development
26.05.09Cerus and Grifols Extend INTERCEPT Blood System Distribution to Italy
14.05.09New Label Claim Expands Market for Cerus’ INTERCEPT Blood System
30.04.09Cerus Corporation Announces First Quarter Financial Results
15.04.09Cerus to Release First Quarter 2009 Financial Results on April 30, 2009
14.04.09Cerus Announces Belgian Contract for Intercept Platelet System
07.04.09Cerus Announces Second Marketing Authorization Granted to Largest Region of German Red Cross
06.04.09Cerus Expands INTERCEPT Product Line With New Set for Platelets
18.03.09Cerus Announces Reduction in Force to Reflect Streamlined Operations
26.02.09Cerus Announces Fourth Quarter and Year-End Results
24.02.09Cerus Announces Marketing Authorization Granted to Largest Region of German Red Cross
12.02.09Cerus to Release Fourth Quarter and Year End 2008 Financial Results on February 26, 2009
02.02.09Cerus Cancels Presentation at BIO CEO & Investor Conference
26.01.09Cerus Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference
04.12.08Cerus Receives Expanded Label Claim for INTERCEPT Plasma System
24.11.08Cerus Initiates Phase I Clinical Trial for INTERCEPT Red Blood Cell System
23.10.08Bacterial Risks Prompt German Safety Measures
20.10.08Cerus Corporation to Release Third Quarter Financial Results
09.10.08Cerus Presents Data on Intercept Blood System at AABB Annual Meeting
01.10.08Cerus to Present at the JMP Securities Healthcare Conference
15.09.08Cerus and German Red Cross to Collaborate on INTERCEPT Red Blood Cell System Development
09.09.08Cerus to Present at the Baird Small Cap Health Care Conference
Seite: 123
Wie bewerten Sie diese Seite?
schlecht sehr gut
Problem mit dieser Seite?
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon